//
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure
Heart Failure With Preserved Ejection Fraction in the Young
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus